Appendix 6. Additional Measures Suggested Through Public Comment

National Advisory Council Subcommittee: Identifying Health Care Quality for Medicaid-Eligible Adults

#	NQF ID^a	Measure Owner	Measure Name
52	0486	CMS	Adoption/Use of Medication Electronic Prescribing Measure
53	NA	NCQA	Adult BMI Assessment
54	0568	IMS Health	Appropriate Follow Up for Patients With HIV/AIDS
55	0429	CREcare	Change in Basic Mobility as Measured by the AM-PAC
56	0430	CREcare	Change in Daily Activity Function as Measured by the AM-PAC
57	0033	NCQA	Chlamydia Screening in Women
58	0102	AMA	Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy
59	0091	AMA	Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation
60	0055	NCQA	Comprehensive Diabetes Care: Eye Exam (Retinal) Performed
61	0449	ASHA	Functional Communication Measure—Attention
62	0448	ASHA	Functional Communication Measure—Memory
63	0447	ASHA	Functional Communication Measure—Motor Speech
64	0446	ASHA	Functional Communication Measure—Reading
65	0445	ASHA	Functional Communication Measure—Spoken Language Comprehension
66	0444	ASHA	Functional Communication Measure—Spoken Language Expression
67	0443	ASHA	Functional Communication Measure—Swallowing
68	0442	ASHA	Functional Communication Measure—Writing
69	NA	NCQA	Glaucoma Screening in Older Adults
70	0641	TJC	HBIPS-3 Hours of Seclusion Use
71	0552	TJC	HBIPS-4 Patients Discharged on Multiple Antipsychotic Medications
72	0560	TJC	HBIPS-5 Patients Discharged on Multiple Antipsychotic Medications with Appropriate Justification
73	0557	TJC	HBIPS-6 Post Discharge Continuing Care Plan Created
74	0558	TJC	HBIPS-7 Post Discharge Continuing Care Plan Transmitted to Next Level of Care Provider upon Discharge
75	0488	CMS	Health Information Technology (HIT): Adoption/Use of Electronic Health Records (EHR)
76	0716	CMQCC	Healthy Term Newborn
77	0397	AMA	Hepatitis C: Antiviral Treatment Prescribed
78	0393	AMA	Hepatitis C: Testing for Chronic Hepatitis C—Confirmation of Hepatitis C Viremia
79	0573	IMS Health	HIV/AIDS Screening: Members at High Risk of HIV/AIDS
80	0406	AMA, NCQA	HIV/AIDS: Adolescent and Adult Patients With HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy
81	0411	NCQA	HIV/AIDS: Hepatitis B Screening
82	0408	NCQA	HIV/AIDS: Tuberculosis (TB) Screening
83	0554	NCQA	Medication Reconciliation Post-Discharge
84	0549	NCQA	Pharmacotherapy of COPD Exacerbation
85	0646	AMA	Reconciled Medication List Received by Discharged Patients (Inpatient Discharges to Home/Self Care or Any Other Site of Care)
86	0119	STS	Risk-Adjusted Operative Mortality for CABG
87	0121	STS	Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement
88	0122	STS	Risk-Adjusted Operative Mortality for MVR + CABG Surgery
89	0402	Asian Liver Center at Stanford University	Screening Foreign-born Adults for Chronic Hepatitis B
90	0333	Leapfrog Group	Severity-Standardized ALOS—Deliveries
91	0436	TJC	STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter
92	0241	AMA, NCQA	Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge
93	0491	CMS	Tracking of Clinical Results Between Visits
94	0577	NCQA	Use of Spirometry Testing in the Assessment and Diagnosis of COPD

^a. NQF ID: National Quality Forum identification numbers are used for measures that are NQF-endorsed; otherwise, NA is used.

Return to Contents
Proceed to Next Section

Current as of December 2010

Internet Citation: Appendix 6. Additional Measures Suggested Through Public Comment: National Advisory Council Subcommittee: Identifying Health Care Quality for Medicaid-Eligible Adults. December 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/events/nac/reports/background/health-care-quality/appendix6.html